Copyright/Patent/Trademark

Education of the impact of online site-blocking proposals on ISPs, internet infrastructure and the consumers of these services. H.R.791 - Foreign Anti-Digital Piracy Act

Education of the impact of online site-blocking proposals on ISPs, internet infrastructure and the consumers of these services. H.R.791 - Foreign Anti-Digital Piracy Act

Copyright

PRO Codes Act - Met with Reps. Nadler, Correa, House Judiciary minority staff HR 6028 - Met with Rep. Loudermilk, Lee, Griffith and House Administration minority staff Site Blocking (including BlockBEARD) - Send. Tillis and Padilla; Reps. Correa, Kiley, Fitzgerald, McClintok, Fry, and Gill

H.R. 4009, Pro Codes Act

Copyright issues relating to the Internet and technology companies; artificial intelligence

Copyright issues relating to libraries; artificial intelligence

Strong intellectual property protections are the foundation for innovation in the life sciences. The U.S. patent system, though now ranked 12th worldwide by the U.S. Chamber of Commerce, maintains important protections for companies researching and developing new medicines and technologies. These protections are especially important for the many small life sciences companies that call Pennsylvania home, and for the technology transfer offices that many of our academic institutions operate to move inventions from the lab to widely available treatments and cures for patients. The University and Small Business Patent Procedures Act Of 1980, more commonly called the Bayh-Dole Act, provides recipients of federal research funding the right to retain ownership of the inventions that were conceived or first actually reduced to practice under their federal funding agreements. Intended to promote utilization of inventions arising from federally supported R&D and increase the number of inventions that progressed from the laboratories into the marketplace. Four decades on, changes to these policies would dramatically disrupt the already fragile ecosystem of academic research institutions, industry partners as well as private investment into treatments that have the potential to extend life expectancy in patients. This does not accurately account for the significant time and resources private investment organizations and companies make to research and develop safe, effective, and usable medicines. Life Sciences Pennsylvania and the academic research institutions as well as R&D based companies that call Pennsylvania home, understand the importance of the strong intellectual property protections that we have in the U.S. Exercising march-in rights will significantly disrupt an innovation ecosystem that already faces challenging odds developing novel therapies and technologies for unmet medical needs. Life Sciences Pennsylvania joins the Partnership for the U.S. Life Science Ecosystem (PULSE) in sharing the unique nature of mergers and acquisitions (M&A) within our membership. To successfully bring cutting edge breakthroughs from bench to bedside-from the earliest NIH funded research in the academic setting through large scale manufacturing, mergers and acquisitions are a cornerstone of the American success of innovation. DOJ and FTC regulatory changes should be nuanced in this space.

H.R.6028, Legislative Branch Agencies Clarification Act Equitable access to digital content/eBooks Copyright law in the digital age (US Copyright Office) Sec. 1201 DMCA proceeding in the US Copyright Office Artificial intelligence with respect to copyright policy, OSTP/EOP Legislation on site blocking Public Modernization Committee of the U.S. Copyright Office H.R. 4072, Protecting and Enhancing Public Access to Codes Act

Raise awareness of intellectual property, supply chain, and public policy issues in the display industry.

Bioscience Intellectual Property

Advocated on issues related to third party marketplace liability, copyright and trademark infringement and issues related to intermediary liability. Shared information on Section 512 of the DMCA and opportunities to improve protections for small creators. Raised concerns for how SHOP SAFE Act would negatively impact small creators.

Issues related to prescription drug pricing.

Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2025. H.R. 4570/S. 1097 Interagency Patent Coordination Act. S. 2658, Medication Affordability and Patent Integrity Act. S. 1096 Preserve Access to Affordable Generics and Biosimilars Act. H.R. 3160 & S. 1533, the PREVAIL Act. S. 1546 & H.R. 3152, the Patent Eligibility Restoration Act of 2025. H.R. 6485 & S.43 Skinny Labels, Big Savings Act. S.1040 Drug Competition Enhancement Act. H.R. 3269 /S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act.

Issues related to intellectual property

Educate members of Congress and administration officials to work to prevent the importation of counterfeit automotive parts. Legislative efforts related to the Trademark Act of 1946 to provide for contributory liability for certain electronic commerce platforms for use of a counterfeit mark by a third party on such platforms, and for other purposes. Advocate with USTO regarding preserving vehicle suppliers right to file inter partes review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB).

Content protection and online piracy Issues concerning the Digital Millennium Copyright Act Digital commerce platform accountability H. Con. Res. 13 / S. Con. Res. 5 - Local Radio Freedom Act H.R. 791 / S. 253 - American Music Fairness Act Issues related to copyright and generative Artificial Intelligence Transparency of Artificial Intelligence models Issues related to AI deepfakes H.R. 2794 / S. 1367 - NO FAKES Act - unauthorized use of AI voice clones and digital replicas S. 5379 - TRAIN Act Website blocking RAP Act - First Amendment protection of lyrical content

Copyright policy issues. Artificial Intelligence issues. Piracy issues.

Biopharmaceutical patent and intellectual property policy issues

Copyright issues. Intellectual property protection.

S. 43: Skinny Labels, Big Savings Act; S. 2276 ETHIC Act; and Intellectual Property.

strategy meetings relating to CGA Tech and IP

Intellectual property.

Antitrust Oversight Issues.

Intellectual property and innovation policy oversight. Patent reform. AI policy.

Domestic Patent Policy and Enforcement. Enforcement of Section 337 Provisions at the International Trade Commission.

Copyright policy issues. Artificial Intelligence issues. Piracy issues.

Copyright Reform. AI Policy. Copyright Office Modernization. International IP Enforcement.

Patent Legislation. Patent Review Procedures. Innovation Policy.

Copyright issues.